Cargando…
Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial
BACKGROUND: There is increasing recognition of the delicate balance between the modest benefits of palliative chemotherapy and the burden of treatment. Decision aids (DAs) can potentially help patients with advanced cancer with these difficult treatment decisions, but providing detailed information...
Autores principales: | Oostendorp, Linda J. M., Ottevanger, Petronella B., Donders, A. Rogier T., van de Wouw, Agnes J., Schoenaker, Ivonne J. H., Smilde, Tineke J., van der Graaf, Winette T. A., Stalmeier, Peep F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580234/ https://www.ncbi.nlm.nih.gov/pubmed/28859646 http://dx.doi.org/10.1186/s12911-017-0529-y |
Ejemplares similares
-
Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
por: Oostendorp, Linda J. M., et al.
Publicado: (2015) -
Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol
por: Oostendorp, Linda JM, et al.
Publicado: (2011) -
Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing
por: Koot, Anna, et al.
Publicado: (2023) -
Cultural values: can they explain self-reported health?
por: Roudijk, Bram, et al.
Publicado: (2017) -
A threshold explanation for the lack of variation in negative composite time trade-off values
por: Roudijk, Bram, et al.
Publicado: (2022)